BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14607217)

  • 1. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.
    Chung LW; Hsieh CL; Law A; Sung SY; Gardner TA; Egawa M; Matsubara S; Zhau HE
    Urology; 2003 Nov; 62(5 Suppl 1):44-54. PubMed ID: 14607217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
    Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.
    Sung SY; Chang JL; Chen KC; Yeh SD; Liu YR; Su YH; Hsueh CY; Chung LW; Hsieh CL
    PLoS One; 2016; 11(4):e0153350. PubMed ID: 27054343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.
    Koeneman KS; Kao C; Ko SC; Yang L; Wada Y; Kallmes DF; Gillenwater JY; Zhau HE; Chung LW; Gardner TA
    World J Urol; 2000 Apr; 18(2):102-10. PubMed ID: 10854144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.
    Hsieh CL; Yang L; Miao L; Yeung F; Kao C; Yang H; Zhau HE; Chung LW
    Cancer Res; 2002 Jun; 62(11):3084-92. PubMed ID: 12036918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.
    Kubo H; Gardner TA; Wada Y; Koeneman KS; Gotoh A; Yang L; Kao C; Lim SD; Amin MB; Yang H; Black ME; Matsubara S; Nakagawa M; Gillenwater JY; Zhau HE; Chung LW
    Hum Gene Ther; 2003 Feb; 14(3):227-41. PubMed ID: 12639303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human prostate cancer progression models and therapeutic intervention.
    Chung LW; Kao C; Sikes RA; Zhau HE
    Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer.
    Li Y; Kacka M; Thompson M; Hsieh JT; Koeneman KS
    Urol Oncol; 2011; 29(6):624-33. PubMed ID: 19963408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
    Shirakawa T; Terao S; Hinata N; Tanaka K; Takenaka A; Hara I; Sugimura K; Matsuo M; Hamada K; Fuji K; Okegawa T; Higashihara E; Gardner TA; Kao C; Chung LW; Kamidono S; Fujisawa M; Gotoh A
    Hum Gene Ther; 2007 Dec; 18(12):1225-32. PubMed ID: 18021019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
    Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
    Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
    Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM
    Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
    Sung SY; Hsieh CL; Law A; Zhau HE; Pathak S; Multani AS; Lim S; Coleman IM; Wu LC; Figg WD; Dahut WL; Nelson P; Lee JK; Amin MB; Lyles R; Johnstone PA; Marshall FF; Chung LW
    Cancer Res; 2008 Dec; 68(23):9996-10003. PubMed ID: 19047182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.